NCT05023967 2026-01-05
Metformin and Nightly Fasting in Women With Early Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
24 trialsNCT04300790 2025-07-29
METALLICA
MedSIR
Phase 2 Completed
NCT02488564 2025-02-03
met-HEReMYTA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02028221 2023-06-27
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
University of Arizona
Phase 2 Completed
NCT05351021 2023-03-09
Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Mansoura University
Phase 2 Completed
NCT04248998 2023-01-18
BREAKFAST
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT02874430 2022-12-15
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Phase 2 Unknown
NCT00930579 2022-10-20
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
Columbia University
Phase 2 Completed
NCT04170465 2022-09-10
METNEO
Damanhour University
Phase 2 Completed
NCT03238495 2021-12-07
HERMET
University of Kansas Medical Center
Phase 2 Unknown
NCT04143282 2021-12-07
Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Beni-Suef University
Phase 2 Completed
NCT05053841 2021-09-23
Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women
Tanta University
Phase 2 Completed
NCT01310231 2021-04-14
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Ozmosis Research Inc.
Phase 2 Completed
NCT04559308 2020-09-22
The Effect of Metformin on Breast Cancer Patients
Beni-Suef University
Phase 2 Unknown
NCT01627067 2020-06-19
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04001725 2019-11-13
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT02506777 2019-09-04
MBC1
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Unknown
NCT02506790 2019-09-04
Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Unknown
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01885013 2016-01-01
MYME
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT00909506 2015-07-29
Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients
Seoul National University Hospital
Phase 2 Completed
NCT01266486 2014-07-02
Effect of Metformin on Breast Cancer Metabolism
Oxford University Hospitals NHS Trust
Phase 2 Completed
NCT01477060 2014-02-20
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
Fondazione Michelangelo
Phase 2 Terminated